MFDS — authorised 17 November 1995
- Marketing authorisation holder: VIIV HLTHCARE
- Status: likely_approved
🇰🇷 Epivir in South Korea
MFDS authorised Epivir on 17 November 1995
Marketing authorisation
Epivir in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Epivir approved in South Korea?
Yes. MFDS authorised it on 17 November 1995.
Who is the marketing authorisation holder for Epivir in South Korea?
VIIV HLTHCARE holds the South Korean marketing authorisation.